{"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"groups":[{"description":"Patients will receive FOLFOX chemotherapy once every two weeks for 6 cycles total over a period of 12 weeks. After completing FOLFOX chemotherapy, the patient will have an MRI scan or endorectal ultrasound (ERUS) to examine the tumor. If the tumor has not decreased in size by at least 20%, the patient will receive 5FUCMT (radiation with chemotherapy). If the tumor has decreased in size by 20%, then the patient will proceed directly to surgery. \\>\n\n\\> If all borders of the tumor are normal post surgery, then the patient receives six additional cycles of FOLFOX chemotherapy. If all borders of the tumor are not normal then the patient receives chemoradiation therapy for 5.5 weeks after surgery. After chemoradiation, additional cycles of FOLFOX or similar chemotherapy will be recommended for 4 cycles or 8 weeks. \\>\n\n\\> FOLFOX (chemotherapy): Oxaliplatin 85 mg/m\\^2 IV over 2 hours on day 1, leucovorin 400 mg/m\\^2 bolus IV over 2 hours on day 1 and 5-fluorouracil 400 mg/m\\^2 bolus over 5-15 minutes then 2400 mg/m\\^2 continual over 46-48 hours total dose IV on days 1-2. The treatment schedule repeats based on the group. \\>\n\n\\> 5 FUCMT (chemoradiation): 5-fluorouracil 225 mg/m\\^2 per day continuous IV infusion administered concurrently with radiation therapy for 5 or 7 days per week OR capecitabine 825 mg/m\\^2 twice daily administered orally and concurrently with radiation therapy for 5 days per week.","id":"BG000","title":"Group 1"},{"description":"Patients receive 5FUCMT including chemotherapy and radiation therapy for 5.5 weeks. Patients will be given either 5-fluorouracil or capecitabine and radiation therapy. After the chemoradiation therapy is completed, patients will proceed directly to surgery. Post-surgery, patients will receive FOLFOX chemotherapy once every two weeks for 8 cycles total over a period of 16 weeks. \\>\n\n\\> FOLFOX (chemotherapy): Oxaliplatin 85 mg/m\\^2 IV over 2 hours on day 1, leucovorin 400 mg/m\\^2 bolus IV over 2 hours on day 1 and 5-fluorouracil 400 mg/m\\^2 bolus over 5-15 minutes then 2400 mg/m\\^2 continual over 46-48 hours total dose IV on days 1-2. The treatment schedule repeats based on the group. Dose modifications are allowed based on adverse events.\\>\n\n\\> 5 FUCMT (chemoradiation): 5-fluorouracil 225 mg/m\\^2 per day continuous IV infusion administered concurrently with radiation therapy for 5 or 7 days per week OR capecitabine 825 mg/m\\^2 twice daily administered orally and concurrently with radiation therapy for 5 days per week. Dose modifications are allowed based on adverse events.\\>\n\n\\> surgery: low anterior resection with total mesorectal excision","id":"BG001","title":"Group 2"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"19","upperLimit":"91","value":"57"},{"groupId":"BG001","lowerLimit":"25","upperLimit":"84","value":"57"},{"groupId":"BG002","lowerLimit":"19","upperLimit":"91","value":"57"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"216"},{"groupId":"BG001","value":"173"},{"groupId":"BG002","value":"389"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"369"},{"groupId":"BG001","value":"370"},{"groupId":"BG002","value":"739"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"48"},{"groupId":"BG001","value":"48"},{"groupId":"BG002","value":"96"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"516"},{"groupId":"BG001","value":"475"},{"groupId":"BG002","value":"991"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"41"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"31"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"50"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"49"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"492"},{"groupId":"BG001","value":"467"},{"groupId":"BG002","value":"959"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"30"},{"groupId":"BG001","value":"40"},{"groupId":"BG002","value":"70"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"51"},{"groupId":"BG001","value":"45"},{"groupId":"BG002","value":"96"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"Canada"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"19"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"Switzerland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"524"},{"groupId":"BG001","value":"489"},{"groupId":"BG002","value":"1013"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"United States"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Country of residence","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"14.5","upperLimit":"65.4","value":"28.4"},{"groupId":"BG001","lowerLimit":"15.8","upperLimit":"81.4","value":"28.1"},{"groupId":"BG002","lowerLimit":"14.5","upperLimit":"81.4","value":"28.3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Body-mass index","unitOfMeasure":"kg/m^2"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"81"},{"groupId":"BG001","value":"83"},{"groupId":"BG002","value":"164"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"504"},{"groupId":"BG001","value":"460"},{"groupId":"BG002","value":"964"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"No"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"History of diabetes","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"106"},{"groupId":"BG001","value":"98"},{"groupId":"BG002","value":"204"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"479"},{"groupId":"BG001","value":"445"},{"groupId":"BG002","value":"924"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"No"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"History of cardiovascular disease","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29"},{"groupId":"BG001","value":"29"},{"groupId":"BG002","value":"58"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"568"},{"groupId":"BG001","value":"531"},{"groupId":"BG002","value":"1099"}],"units":"Participants"}],"title":"Less than high school"},{"categories":[{"measurements":[{"groupId":"BG000","value":"214"},{"groupId":"BG001","value":"201"},{"groupId":"BG002","value":"415"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"High school diploma or GED certificate"},{"categories":[{"measurements":[{"groupId":"BG000","value":"119"},{"groupId":"BG001","value":"102"},{"groupId":"BG002","value":"221"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"Some college"},{"categories":[{"measurements":[{"groupId":"BG000","value":"206"},{"groupId":"BG001","value":"199"},{"groupId":"BG002","value":"405"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"College degree or higher"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Missing Patient Data","title":"Highest education level","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"582"},{"groupId":"BG001","value":"540"},{"groupId":"BG002","value":"1122"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"0 or 1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"6"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"2"}],"description":"ECOG = 0: Fully active, able to carry on all pre-disease performance without restriction. \\> ECOG = 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. \\> ECOG = 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours. \\> ECOG = 0 is better. ECOG = 2 is worse.","paramType":"COUNT_OF_PARTICIPANTS","title":"ECOG performance-status score","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"290"},{"groupId":"BG001","value":"259"},{"groupId":"BG002","value":"549"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"580"},{"groupId":"BG001","value":"536"},{"groupId":"BG002","value":"1116"}],"units":"Participants"}],"title":"Rectal tumor not palpable"},{"categories":[{"measurements":[{"groupId":"BG000","value":"290"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"567"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"Rectal tumor palpable"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Missing Patient Data","title":"Primary rectal tumor on digital examination","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"2","upperLimit":"25","value":"8"},{"groupId":"BG001","lowerLimit":"2","upperLimit":"18","value":"8"},{"groupId":"BG002","lowerLimit":"2","upperLimit":"25","value":"8"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Rectal tumor location","unitOfMeasure":"cm"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"83"},{"groupId":"BG001","value":"89"},{"groupId":"BG002","value":"172"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"≤5 cm from anal verge"},{"categories":[{"measurements":[{"groupId":"BG000","value":"375"},{"groupId":"BG001","value":"344"},{"groupId":"BG002","value":"719"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":">5 to ≤10 cm from anal verge"},{"categories":[{"measurements":[{"groupId":"BG000","value":"127"},{"groupId":"BG001","value":"109"},{"groupId":"BG002","value":"236"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":">10 cm from anal verge"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Rectal tumor location","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"63"},{"groupId":"BG001","value":"38"},{"groupId":"BG002","value":"101"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"584"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1127"}],"units":"Participants"}],"title":"T2 node positive"},{"categories":[{"measurements":[{"groupId":"BG000","value":"232"},{"groupId":"BG001","value":"198"},{"groupId":"BG002","value":"430"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"T3 node negative"},{"categories":[{"measurements":[{"groupId":"BG000","value":"289"},{"groupId":"BG001","value":"307"},{"groupId":"BG002","value":"596"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"T3 node positive"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"T1 is if the maximum pre-biopsy diameter was ≤ 2 cm and had at most one of the following high-risk features: poorly differentiated histology, location on the mucosal (non-hair bearing) lip or ear, presence of perineural invasion, or depth of invasion to Clark's level ≥ IV or \\> 2 mm.T2 is if \\> 2 cm in maximum pre-biopsy diameter or had ≥ 2 of the 7th edition AJCC high-risk features. T3 is if invaded the one or more of the facial bones (including the maxilla, mandible, orbit, or temporal bones.","title":"Clinical stage","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"494"},{"groupId":"BG001","value":"458"},{"groupId":"BG002","value":"952"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"91"},{"groupId":"BG001","value":"85"},{"groupId":"BG002","value":"176"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"585"},{"groupId":"BG001","value":"543"},{"groupId":"BG002","value":"1128"}],"units":"Participants"}],"title":"No"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Staging performed with MRI","unitOfMeasure":"Participants"}]}